Insufficient and Poor Sleep in Teen Years Increases Risk of MS: Study
Teenagers with poor sleep quality or insufficient sleep — those who sleep less than seven hours a night — are…
Articles by Steve Bryson, PhD
Early Progression Independent of Relapses Linked to Worse Disability
Within the first 12 years after the onset of symptoms, about one-fourth of people with clinically isolated syndrome —…
Use of Virtual Reality Physiotherapy in MS Found to Boost Adherence
Uses of virtual reality-based physiotherapy to improve balance and gait in people with multiple sclerosis (MS) are linked to…
Alcohol Consumption Is No Protection From MS: UK Study
The risk of developing multiple sclerosis (MS) doesn’t seem to be influenced by consuming alcohol, according to a large-scale…
Stem Cell Transplant More Effective for SPMS Than Medications: Study
A stem cell transplant more effectively slowed disability worsening in people with active secondary progressive multiple sclerosis (SPMS)…
Myelin Provides Metabolic Support to Inhibitory Brain Cells: Study
Myelin, the fatty-rich material surrounding nerve fibers that’s progressively damaged in multiple sclerosis (MS), provides metabolic support to…
Lcn-2 Protein Marks Intestinal Inflammation in MS, Study Shows
People with relapsing-remitting multiple sclerosis (RRMS) have elevated levels of the lipocalin 2 (Lcn-2) protein in their stool samples,…
RRMS Transition to SPMS Fell With Start of DMTs, Swedish Study Finds
The risk of transitioning from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) declined significantly after…
For MS Patients in Japan, Kesimpta May Be Best at Preventing Relapses
Kesimpta (ofatumumab) may be more effective at reducing relapse rates than other disease-modifying therapies (DMTs) in Japanese adults with…
Estriol Plus Copaxone May Protect Against Nerve Damage in RRMS
Taking the pregnancy hormone estriol in combination with Copaxone (glatiramer acetate) significantly reduced the blood levels of neurofilament light…
Signal Detection Theory May Help Measure MS Cognitive Fatigue
A new tool called signal detection theory (SDT) found a relationship between subjective cognitive fatigue, often experienced by people with…
No Thyroid Problems With DMF Therapy, Records Study Concludes
Treatment with the approved multiple sclerosis (MS) therapy dimethyl fumarate (DMF) did not affect the function of the thyroid…
Most Patients Adhere to Betaseron Therapy Over 1 Year, App Data Show
Multiple sclerosis (MS) patients treated with Betaseron (interferon beta-1b) had over 90% treatment compliance — the percentage of…
Key to Unlocking Blood-brain Barrier Discovered in Mouse Study
A team of researchers has discovered that the key to bypassing the blood-brain barrier — a semipermeable border that protects…
3D Showing of Mayzent Binding to Receptor Could Advance Treatments
For the first time, researchers have brought to light the precise three-dimensional structure of Mayzent (siponimod) as it binds to…
MS Focus of Paralyzed Veterans of America’s Newest Committee
Paralyzed Veterans of America (PVA) has formed a committee to better address the needs and interests of veterans with…
Using Trait Mindfulness Techniques May Help Reduce Depression in MS
Multiple sclerosis (MS) patients reported fewer difficulties regulating their emotions, and reduced depressive symptoms when they applied trait mindfulness…
Life Quality of Children With MS Affected by Parents’ Distress: Study
The psychological distress of a parent whose child is found to have multiple sclerosis (MS) may directly impact the…
‘Cellular Big Bang’ Reveals Immune Driver in Study of Twins
An increased production of CD25 – an immune receptor that regulates T-cell proliferation and activation – is the most noticeable…
Newly Created Cells Better at Repairing Myelin in Preclinical Study
Therapeutics designed to produce new oligodendrocytes — the cells responsible for the protective myelin sheath that is damaged in…
VISIONARY-MS Trial of CNM-Au8 to End Early Due to Pandemic
VISIONARY-MS, a Phase 2 clinical trial evaluating the safety and effectiveness of CNM-Au8 in people with relapsing multiple…
Exergames May Improve Balance Better Than Standard Rehab
Exergames — playing video games that involve physical exercise — may be more effective at improving balance in people with…
Vitamin D Supplements May Improve MS Quality of Life
Vitamin D supplementation may improve quality of life in people with multiple sclerosis (MS), according to a literature review…
Higher, Fewer Copaxone Doses Lowered Relapse Rates Over 7 YearsÂ
A higher dose of Copaxone (glatiramer acetate) given three times weekly over seven years led to sustainably lower relapse…
Oral Contraceptives Do Not Increase Risk of 2nd Attack, Worse Disease
The use of oral contraceptives does not increase the risk of a second attack of symptoms or the progression of…
Aubagio Reduces Lesions in Children in Trial, but Relapse Data Troubled
Aubagio (teriflunomide) failed to significantly reduce relapses in children with multiple sclerosis (MS), but two years of treatment…
Vitamin D Deficiency Linked to Early Cognitive Difficulties in Study
Low vitamin D levels in the bloodstream are associated with slower information processing speeds in people with early-stage multiple sclerosis…
Robotic Devices Help Improve Walking for Those with Severe Deficits
Using robotic devices during gait training can improve walking abilities in people with multiple sclerosis (MS), particularly among those…
Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People
A single dose of NVG-291, a potential nerve repair therapy for multiple sclerosis (MS), was safe and well-tolerated…
Coated Vesicles Found to Safely Reduce Disease Progression in Mice
Extracellular vesicles or EVs — tiny sacs of material excreted by cells — that have been coated with protein receptors…